VBR vs IWO: returns, risk and drawdowns compared
Vanguard Small-Cap Value ETF against iShares Russell 2000 Growth ETF, over the same 6 years (July 2020 to October 2026) with dividends reinvested.
Data updated October 2026
VBR
Vanguard Small-Cap Value ETF
10,000 became
25,078
- A year on average
- +15.6%
- Annual volatility
- 18.6%
- Deepest fall
- −18.7%
- Worst month
- −10.3%
IWO
iShares Russell 2000 Growth ETF
10,000 became
17,189
- A year on average
- +8.9%
- Annual volatility
- 21.7%
- Deepest fall
- −33.5%
- Worst month
- −13.4%
VBR came out ahead by 6.7 percentage points a year from July 2020 to October 2026. IWO swung more (21.7% against 18.6% a year). The correlation of monthly returns was 0.87: they usually moved together.
Growth of 10,000: VBR vs IWO
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero VBR had returned more, below zero IWO. VBR was ahead in 63% of the 41 three-year periods.
Annualised 3-year return of VBR minus that of IWO, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: VBR −18.7%, IWO −33.5%.
All the figures
| VBR | IWO | |
|---|---|---|
| Annual return (CAGR) | +15.6% | +8.9% |
| Total return | +151% | +72% |
| Annual volatility | 18.6% | 21.7% |
| Deepest fall (month-end) | −18.7% | −33.5% |
| Worst month | −10.3% | −13.4% |
| Best month | +17.4% | +17.7% |
| Positive months | 62% | 54% |
| Best year | 2021: +28.1% | 2023: +18.5% |
| Worst year | 2022: −9.4% | 2022: −26.3% |
| 1-year return | +16.8% | +6.2% |
| 5 years, a year | +8.2% | +3.2% |
| 10 years, a year | — | +9.8% |
| Trading currency | USD | USD |
First nine rows: the same 76 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half VBR, half IWO
| VBR alone | IWO alone | 50/50 | |
|---|---|---|---|
| A year on average | +15.6% | +8.9% | +12.4% |
| Annual volatility | 18.6% | 21.7% | 19.5% |
| Deepest fall (month-end) | −18.7% | −33.5% | −25.0% |
| Worst month | −10.3% | −13.4% | −9.4% |
Because the two did not always move together, the mix swung less than the average of the two (19.5% against 20.2%). Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, VBR or IWO?
From July 2020 to October 2026, VBR returned +15.6% a year and IWO +8.9% a year, with dividends reinvested. Over rolling 3-year periods VBR did better in 63% of cases. Past returns do not predict future returns.
Which is riskier, VBR or IWO?
Over the same months annual volatility was 18.6% for VBR and 21.7% for IWO; the deepest fall from a month-end high was 18.7% and 33.5%, and the worst single month −10.3% and −13.4%.
How correlated are VBR and IWO?
The correlation of their monthly returns was 0.87: they usually moved together. Combining them has historically given some diversification.
What about holding both VBR and IWO?
Half in each, rebalanced every month, returned +12.4% a year over the same period, with 19.5% annual volatility and a deepest month-end fall of 25.0%.
More comparisons
- VBR — Vanguard Small-Cap Value ETFReturns, drawdowns and risk
- IWO — iShares Russell 2000 Growth ETFReturns, drawdowns and risk
- AVUV vs VBR
- VBR vs IWN
- AVUV vs IWO
- IWN vs IWO
- Portfolio stress test with custom shocksYour own scenarios, holding by holding
- Best portfolio analytics tools (2026)Features and prices side by side
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.